Correlation Between Lees Pharmaceutical and Cannara Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lees Pharmaceutical and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lees Pharmaceutical and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lees Pharmaceutical Holdings and Cannara Biotech, you can compare the effects of market volatilities on Lees Pharmaceutical and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lees Pharmaceutical with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lees Pharmaceutical and Cannara Biotech.

Diversification Opportunities for Lees Pharmaceutical and Cannara Biotech

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lees and Cannara is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Lees Pharmaceutical Holdings and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Lees Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lees Pharmaceutical Holdings are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Lees Pharmaceutical i.e., Lees Pharmaceutical and Cannara Biotech go up and down completely randomly.

Pair Corralation between Lees Pharmaceutical and Cannara Biotech

If you would invest  47.00  in Cannara Biotech on October 25, 2024 and sell it today you would earn a total of  15.00  from holding Cannara Biotech or generate 31.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy1.67%
ValuesDaily Returns

Lees Pharmaceutical Holdings  vs.  Cannara Biotech

 Performance 
       Timeline  
Lees Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lees Pharmaceutical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Lees Pharmaceutical is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Cannara Biotech 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Lees Pharmaceutical and Cannara Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lees Pharmaceutical and Cannara Biotech

The main advantage of trading using opposite Lees Pharmaceutical and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lees Pharmaceutical position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.
The idea behind Lees Pharmaceutical Holdings and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk